Opportunities, controversies and challenges of extracorporeal hemoadsorption with CytoSorb® during ECMO

to connected objects

Abstract: Extracorporeal membrane oxygenation (ECMO) is frequently used in many centers around the globe for various indications. However, prognosis is often poor even with all supportive therapies, and in many cases, clinical deterioration is associated with inflammation. Hemoadsorption with CytoSorb is a novel approach to limit the inflammatory response, and the device can be safely and easily installed into ECMO circuits. CytoSorb has been used more than 130.000 times to date, but because randomized controlled trials are largely lacking, there is substantial debate on its use. Here, experts from critical care medicine, cardiology, cardiac surgery, and perfusion technology discuss the pros and cons of this novel therapy and outline the future aspects for its clinical application and research

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch
Notes
Artificial organs. - 45, 10 (2021) , 1240-1249, ISSN: 1525-1594

Event
Veröffentlichung
(where)
Freiburg
(who)
Universität
(when)
2021
Creator
Napp, Christian
Lebreton, Guillaume
Somer, Filip de
Supady, Alexander
Pappalardo, Federico

DOI
10.1111/aor.14025
URN
urn:nbn:de:bsz:25-freidok-2194921
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:54 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

Time of origin

  • 2021

Other Objects (12)

Clinical use of an extracorporeal membrane oxygenator (ECMO) in neonatal pulmonary failure.

Clinical use of an extracorporeal membrane oxygenator (ECMO) in neonatal pulmonary failure.

A mortality prediction score for patients with veno-venous extracorporeal membrane oxygenation (VV-ECMO): the PREDICT VV-ECMO score

A mortality prediction score for patients with veno-venous extracorporeal membrane oxygenation (VV-ECMO): the PREDICT VV-ECMO score

Comment on : : Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO

Comment on : : Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO

Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure – a clinical practice Guideline Level 3

Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure – a clinical practice Guideline Level 3

Vorrede (sorb.)

Vorwort

Vorrede (sorb.)

Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: consensus paper of the Medical University of Vienna

Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: consensus paper of the Medical University of Vienna

Exposure of patients to di(2-ethylhexy)phthalate (DEHP) and its metabolite MEHP during extracorporeal membrane oxygenation (ECMO) therapy

Exposure of patients to di(2-ethylhexy)phthalate (DEHP) and its metabolite MEHP during extracorporeal membrane oxygenation (ECMO) therapy

Excessive unbound cefazolin concentrations in critically ill patients receiving veno-arterial extracorporeal membrane oxygenation (vaECMO): an observational study

Excessive unbound cefazolin concentrations in critically ill patients receiving veno-arterial extracorporeal membrane oxygenation (vaECMO): an observational study

Iris Brankatschk (sorb. Iris Brankačkowa, *1958), Bautzen; sorb. Malerin, Buchgestalterin

Fotografie

Iris Brankatschk (sorb. Iris Brankačkowa, *1958), Bautzen; sorb. Malerin, Buchgestalterin

Historical Controversies

Abschnitt

Historical Controversies

Syntactic controversies

Syntactic controversies

ECMO - Leitfaden für Pflegende

ECMO - Leitfaden für Pflegende

Related objects